Mgo One Seven LLC Guardant Health, Inc. Transaction History

Mgo One Seven LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$25.8 - $39.97 $5,908 - $9,153	-229 Reduced 2.27%	9,875 $292,000
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $4,397 - $7,982	210 Added 2.12%	10,104 $361,000
Q1 2023 May 08, 2023	BUY	$22.92 - $33.76 $2,842 - $4,186	124 Added 1.27%	9,894 $231,000
Q4 2022 Jan 25, 2023	BUY	$25.44 - $59.78 $105,906 - $248,864	4,163 Added 74.25%	9,770 $0
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $6,767 - $9,455	155 Added 2.84%	5,607 $346,000
Q2 2022 Aug 10, 2022	BUY	$28.82 - $77.35 $1,325 - $3,558	46 Added 0.85%	5,452 $220,000
Q1 2022 May 13, 2022	BUY	$48.25 - $100.49 $260,839 - $543,248	5,406 New	5,406 $358,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.